ÂÜÀòÂÒÂ×

Sean Russell has a strong background in regulatory affairs, with extensive experience in the pharmaceutical industry. Sean is the Chief Operating Officer at Model Medicines since March 2023. Prior to this role, they were the Vice President of Regulatory Affairs at Model Medicines from October 2020 to February 2023, and the Head of Regulatory Affairs from May 2019 to September 2020. Before joining Model Medicines, Sean served as the President of Foundation Regulatory Consulting since July 2013. Sean also held positions at SAGE Therapeutics as Director of Regulatory Operations from December 2015 to February 2018, Noven Pharmaceuticals as Associate Director of Regulatory Affairs from May 2011 to July 2013, Lux Biosciences as Associate Director and Head of Regulatory Affairs from January 2009 to May 2011, and Manager of Regulatory Affairs and Compliance from August 2007 to December 2008. Sean's earlier career includes roles at Watson Pharmaceuticals as Manager of Regulatory Affairs from September 2005 to April 2007, Ranbaxy Pharmaceuticals as a Regulatory Affairs Associate from June 2003 to September 2005, and Bristol-Myers Squibb as a Regulatory Affairs Associate from January 2001 to June 2003, and as a Regulatory Safety Associate from September 1999 to January 2001. Prior to their industry career, Sean served in the United States Air Force as a Radiological Technologist and Diagnostic Imaging Floor Manager from August 1995 to August 1999.

Sean Russell attended the Community College of the Air Force from 1995 to 1999, where they obtained a Radiology Certification with a focus on Radiological Sciences. Additionally, they pursued a degree in Business Administration from the University of Phoenix, but the specific start and end years of their enrollment are not provided.